Latest news
Rule 10b5-1 plan drives Moderna, Inc. (NASDAQ: MRNA) CEO stock sales - Stock TitanStock Titan · Fri, 07 Aug 2026 20:12:01 GMTFDA Approves First mRNA Flu Shot for Adults 50 and Older - South Florida ReporterSouth Florida Reporter · Thu, 06 Aug 2026 05:12:07 GMTModerna's first mRNA flu vaccine approved for adults 50+ - Stock TitanStock Titan · Thu, 06 Aug 2026 02:18:30 GMTModerna vaccinates first participants in trial for Ebola strain with no vaccine - Stock TitanStock Titan · Tue, 04 Aug 2026 15:00:00 GMTModerna (NASDAQ: MRNA) Q2 2026 loss, trims 2026 spending - Stock TitanStock Titan · Fri, 31 Jul 2026 11:04:17 GMTModerna's Flu Vaccine Could Become Its Fifth Approved Product - Stock TitanStock Titan · Fri, 31 Jul 2026 07:00:00 GMTModerna Q2 Results: Loss beats estimates, sales rise to $145 million - scanx.tradescanx.trade · Fri, 31 Jul 2026 07:00:00 GMT